To define the impact of geminin on human ovarian cancer initiation and progression, geminin-depleted HGSOC cells were established by treating A2780 cells using shRNA to knock out endogenous geminin (Figure 1A, Supplementary Table S1). This evidence concerns the gene GMNN and ovarian cancer.